Xian International Medical Investment Co Ltd Market Cap ($1.50 Billion)
Market Cap & Net Worth: Xian International Medical Investment Co Ltd (000516)
Xian International Medical Investment Co Ltd market cap. Xian International Medical Investment Co Ltd (SHE:000516) has a market capitalization of $1.50 Billion (CN¥10.25 Billion) as of November 6, 2026. Listed on the SHE stock exchange, this China-based company holds position #7008 globally and #1425 in its home market, demonstrating a 5.53% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xian International Medical Investment Co Ltd's stock price CN¥4.58 by its total outstanding shares 2238896753 (2.24 Billion). Also see Xian International Medical Investment Co (000516) cash conversion ratio for how efficiently the company converts equity into cash flow.
Xian International Medical Investment Co Ltd Market Cap History (2015–2026)
Xian International Medical Investment Co Ltd market cap history from 2015 to 2026. Data shows change from $2.81 Billion to $1.50 Billion (-3.81% CAGR). Check latest Xian International Medical Investment Co stock price today for real-time trading data and today's change.
Xian International Medical Investment Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Xian International Medical Investment Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 000516 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.34x
Xian International Medical Investment Co Ltd's market cap is 0.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.53 Billion | $3.93 Billion | $201.59 Million | 0.64x | 12.56x |
| 2017 | $1.58 Billion | $4.06 Billion | $194.54 Million | 0.39x | 8.10x |
| 2018 | $1.59 Billion | $2.04 Billion | $2.18 Billion | 0.78x | 0.73x |
| 2019 | $1.59 Billion | $990.95 Million | -$403.93 Million | 1.60x | N/A |
| 2020 | $4.12 Billion | $1.61 Billion | $45.36 Million | 2.56x | 90.79x |
| 2021 | $3.61 Billion | $2.92 Billion | -$822.17 Million | 1.24x | N/A |
| 2022 | $4.01 Billion | $2.71 Billion | -$1.18 Billion | 1.48x | N/A |
| 2023 | $2.66 Billion | $4.62 Billion | -$368.36 Million | 0.58x | N/A |
| 2024 | $1.73 Billion | $4.82 Billion | -$254.13 Million | 0.36x | N/A |
| 2025 | $1.41 Billion | $4.07 Billion | -$313.08 Million | 0.34x | N/A |
Competitor Companies of 000516 by Market Capitalization
Companies near Xian International Medical Investment Co Ltd in the global market cap rankings as of November 6, 2026. Also see how large is Xian International Medical Investment Co's balance sheet for a full breakdown of the balance sheet.
Key companies related to Xian International Medical Investment Co Ltd by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #905 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #994 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1215 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $510.70 |
| #905 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €51.38 |
| #994 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1215 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $292.25 |
Market Capitalization of Xian International Medical Investment Co Ltd (2015–2026)
Market capitalization of Xian International Medical Investment Co Ltd from 2015 to today. Between 2015 and today, Xian International Medical Investment Co Ltd's market cap moved from $2.81 Billion to $ 1.50 Billion, with a yearly change of -3.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.50 Billion | +6.76% |
| 2025 | CN¥1.41 Billion | -18.75% |
| 2024 | CN¥1.73 Billion | -34.90% |
| 2023 | CN¥2.66 Billion | -33.74% |
| 2022 | CN¥4.01 Billion | +10.97% |
| 2021 | CN¥3.61 Billion | -12.25% |
| 2020 | CN¥4.12 Billion | +159.18% |
| 2019 | CN¥1.59 Billion | -0.36% |
| 2018 | CN¥1.59 Billion | +1.23% |
| 2017 | CN¥1.58 Billion | -37.76% |
| 2016 | CN¥2.53 Billion | -9.93% |
| 2015 | CN¥2.81 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Xian International Medical Investment Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.50 Billion USD |
| MoneyControl | $1.50 Billion USD |
| MarketWatch | $1.50 Billion USD |
| marketcap.company | $1.50 Billion USD |
| Reuters | $1.50 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Xian International Medical Investment Co Ltd
Xi'an International Medical Investment Company Limited provides healthcare services in China. It operates hospitals and medical centers. The company also engages in insurance broking, E-commerce, health and asset management, tourism, professional design, technological development, food and beverages, and pharmaceutical production business. The company was formerly known as Xi'an Kaiyuan Investmen… Read more